Deletion of glycogen synthase kinase-3β in cartilage results in up-regulation of glycogen synthase kinase-3α protein expression

Endocrinology

Volumn 152, Issue 5, 2011, Pages 1755-1756

  Gillespie, J R ^a   Ulici, V ^a   Dupuis, H ^a   Higgs, A ^a   Dimattia, A ^a   Patel, S ^c   Woodgett, J R ^c   Beier, F ^a,b,d  

^a WESTERN UNIVERSITY   (Canada)

^b CHILDREN S HEALTH RESEARCH INSTITUTE   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE GROWTH; BONE TURNOVER; CARTILAGE CELL; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; GENE DELETION; GENE INACTIVATION; GENETIC ANALYSIS; GENOTYPE; GROWTH PLATE; IN VIVO STUDY; MOUSE; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TIBIA; UPREGULATION;

AMINOPHENOLS; ANIMALS; BETA CATENIN; BLOTTING, WESTERN; CARTILAGE; CELL PROLIFERATION; CHONDROCYTES; FEMALE; GENE DELETION; GLYCOGEN SYNTHASE KINASE 3; GROWTH PLATE; IMMUNOHISTOCHEMISTRY; MALE; MALEIMIDES; MICE; MICE, KNOCKOUT; ORGAN CULTURE TECHNIQUES; PHOSPHATIDYLINOSITOL 3-KINASES; TIBIA; UP-REGULATION;

EID: 79955433042     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-1412     Document Type: Article

References (65)

1. Kronenberg HM 2003 Developmental regulation of the growth plate. Nature 423:332-336 (Pubitemid 40852707)
2. Provot S, Schipani E 2005 Molecular mechanisms of endochondral bone development. Biochem Biophys Res Commun 328:658-665 (Pubitemid 40208303)
3. Mackie EJ, Ahmed YA, Tatarczuch L, Chen KS, Mirams M 2008 Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol 40:46-62 (Pubitemid 350052658)
4. Karsenty G, Wagner EF 2002 Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2:389-406 (Pubitemid 34436569)
5. Kobayashi T, Kronenberg H 2005 Transcriptional regulation in development of bone. Endocrinology 146:1012-1017
6. Wagner EF, Karsenty G 2001 Genetic control of skeletal development. Curr Opin Genet Dev 11:527-532 (Pubitemid 32800726)
7. Baron R, Rawadi G 2007 Targeting the Wnt/β-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 148:2635-2643 (Pubitemid 46984775)
8. Glass 2nd DA, Karsenty G 2007 In vivo analysis of Wnt signaling in bone. Endocrinology 148:2630-2634 (Pubitemid 46984774)
9. Nilsson O, Marino R, De Luca F, Phillip M, Baron J 2005 Endocrine regulation of the growth plate. Horm Res 64:157-165 (Pubitemid 41642759)
10. Huang W, Chung UI, Kronenberg HM, de Crombrugghe B 2001 The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. Proc Natl Acad Sci USA 98:160-165 (Pubitemid 32095880)
11. van der Eerden BC, Karperien M, Wit JM 2003 Systemic and local regulation of the growth plate. Endocr Rev 24:782-801 (Pubitemid 38067699)
12. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA 1995 Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789 (Pubitemid 26004411)
13. Hooper PL 2007 Insulin signaling, GSK-3, heat shock proteins and the natural history of type 2 diabetes mellitus: a hypothesis. Metab Syndr Relat Disord 5:220-230 (Pubitemid 47402028)
14. McManus EJ, Sakamoto K, ArmitLJ, Ronaldson L, Shpiro N, Marquez R, Alessi DR 2005 Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J 24:1571-1583 (Pubitemid 40646447)
15. Ulici V, Hoenselaar KD, Gillespie JR, Beier F 2008 The PI3K pathway regulates endochondral bone growth through control of hypertrophic chondrocyte differentiation. BMC Dev Biol 8:40
16. Patel S, Doble BW, MacAulay K, Sinclair EM, Drucker DJ, Woodgett JR 2008 Tissue-specific role of glycogen synthase kinase-3β in glucose homeostasis and insulin action. Mol Cell Biol 28:6314-6328
17. Doble BW, Patel S, Wood GA, Kockeritz LK, Woodgett JR 2007 Functional redundancy of GSK-3α and GSK-3β in Wnt/β-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev Cell 12:957-971 (Pubitemid 46805920)
18. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A 1998 Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J 17:1371-1384 (Pubitemid 28105516)
19. Welsh GI, Proud CG 1993 Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem J 294 (Pt 3):625-629 (Pubitemid 23286543)
20. Woodgett JR 2001 Judging a protein by more than its name: GSK-3. Sci STKE 2001: re12.
21. Patel S, Doble B, Woodgett JR 2004 Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword? Biochem Soc Trans 32:803-808 (Pubitemid 39524384)
22. Doble BW, Woodgett JR 2003 GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116:1175-1186 (Pubitemid 36410657)
23. Baryawno N, Sveinbjörnsson B, Eksborg S, Chen CS, Kogner P, Johnsen JI 2010 Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/β-catenin pathway cross-talk and suppress medulloblastoma growth. Cancer Res 70:266-276
24. Kawasaki Y, Kugimiya F, Chikuda H, Kamekura S, Ikeda T, Kawamura N, Saito T, Shinoda Y, Higashikawa A, Yano F, Ogasawara T, Ogata N, Hoshi K, Hofmann F, Woodgett JR, Nakamura K, Chung UI, Kawaguchi H 2008 Phosphorylation of GSK-3β by cGMP-dependent protein kinase II promotes hypertrophic differentiation of murine chondrocytes. J Clin Invest 118:2506-2515 (Pubitemid 351949778)
25. Ng SS, Mahmoudi T, Danenberg E, Bejaoui I, de Lau W, Korswagen HC, Schutte M, Clevers H 2009 Phosphatidylinositol 3-kinase signaling does not activate the wnt cascade. J Biol Chem 284:35308-35313
26. Bommer GT, Feng Y, Iura A, Giordano TJ, Kuick R, Kadikoy H, Sikorski D, Wu R, Cho KR, Fearon ER 2010 IRS1 regulation by Wnt/β-catenin signaling and varied contribution of IRS1 to the neoplastic phenotype. J Biol Chem 285:1928-1938
27. Wang L, Shao YY, Ballock RT 2010 Thyroid hormone-mediated growth and differentiation of growth plate chondrocytes involves IGF-1 modulation of β-catenin signaling. J Bone Miner Res 25:1138-1146
28. Matsuda T, Zhai P, Maejima Y, Hong C, Gao S, Tian B, Goto K, Takagi H, Tamamori-Adachi M, Kitajima S, Sadoshima J 2008 Distinct roles of GSK-3α and GSK-3β phosphorylation in the heart under pressure overload. Proc Natl Acad Sci USA 105:20900-20905
29. Liang MH, Chuang DM 2006 Differential roles of glycogen synthase kinase-3 isoforms in the regulation of transcriptional activation. J Biol Chem 281:30479-30484
30. Force T, Woodgett JR 2009 Unique and overlapping functions of GSK-3 isoforms in cell differentiation and proliferation and cardiovascular development. J Biol Chem 284:9643-9647
31. Cho J, Rameshwar P, Sadoshima J 2009 Distinct roles of glycogen synthase kinase (GSK)-3α and GSK-3β in mediating cardiomyocyte differentiation in murine bone marrow-derived mesenchymal stem cells. J Biol Chem 284:36647-36658
32. Ciaraldi TP, Oh DK, Christiansen L, Nikoulina SE, Kong AP, Baxi S, Mudaliar S, Henry RR 2006 Tissue-specific expression and regulation of GSK-3 in human skeletal muscle and adipose tissue. Am J Physiol Endocrinol Metab 291: E891-E898
33. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR 2000 Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation. Nature 406:86-90 (Pubitemid 30460216)
34. Liu KJ, Arron JR, Stankunas K, Crabtree GR, Longaker MT 2007 Chemical rescue of cleft palate and midline defects in conditional GSK-3β mice. Nature 446:79-82 (Pubitemid 46348041)
35. Kugimiya F, Kawaguchi H, Ohba S, Kawamura N, Hirata M, Chikuda H, Azuma Y, Woodgett JR, Nakamura K, Chung UI 2007 GSK-3β controls osteogenesis through regulating Runx2 activity. PLoS ONE 2: e837
36. MacAulay K, Doble BW, Patel S, Hansotia T, Sinclair EM, Drucker DJ, Nagy A, Woodgett JR 2007 Glycogen synthase kinase 3α-specific regulation of murine hepatic glycogen metabolism. Cell Metab 6:329-337 (Pubitemid 47450185)
37. Kaidanovich-Beilin O, Lipina TV, Takao K, van Eede M, Hattori S, Laliberté C, Khan M, Okamoto K, Chambers JW, Fletcher PJ, Macaulay K, Doble BW, Henkelman M, Miyakawa T, Roder J, Woodgett JR 2009 Abnormalities in brain structure and behavior in GSK-3α mutant mice. Mol Brain 2:35
38. Tanabe K, Liu Z, Patel S, Doble BW, Li L, Cras-Méneur C, Martinez SC, Welling CM, White MF, Bernal-Mizrachi E, Woodgett JR, Permutt MA 2008 Genetic deficiency of glycogen synthase kinase-3β corrects diabetes in mouse models of insulin resistance. PLoS Biol 6: e37
39. Wang G, Woods A, Agoston H, Ulici V, Glogauer M, Beier F 2007 Genetic ablation of Rac1 in cartilage results in chondrodysplasia. Dev Biol 306:612-623 (Pubitemid 46873537)
40. Solomon LA, Li JR, Bérubé NG, Beier F 2009 Loss of ATRX in chondrocytes has minimal effects on skeletal development. PLoS One 4: e7106
41. Agoston H, Khan S, James CG, Gillespie JR, Serra R, Stanton LA, Beier F 2007 C-type natriuretic peptide regulates endochondral bone growth through p38 MAP kinase-dependent and-independent pathways. BMC Dev Biol 7:18
42. Cross DA, Culbert AA, Chalmers KA, Facci L, Skaper SD, Reith AD 2001 Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death. J Neurochem 77:94-102 (Pubitemid 32245083)
43. Ulici V, Hoenselaar KD, Agoston H, McErlain DD, Umoh J, Chakrabarti S, Holdsworth DW, Beier F 2009 The role of Akt1 in terminal stages of endochondral bone formation: angiogenesis and ossification. Bone 45:1133-1145
44. Yan Q, Feng Q, Beier F 2010 Endothelial nitric oxide synthase deficiency results in reduced chondrocyte proliferation and endochondral bone growth. Arthritis Rheum 62:2013-2022
45. Stanton LA, Sabari S, Sampaio AV, Underhill TM, Beier F 2004 p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation. Biochem J 378:53-62 (Pubitemid 38299543)
46. Sutherland C, Leighton IA, Cohen P 1993 Inactivation of glycogen synthase kinase-3β by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 296 (Pt 1):15-19 (Pubitemid 23344723)
47. Wang J, Zhou J, Bondy CA 1999 Igf1 promotes longitudinal bone growth by insulin-like actions augmenting chondrocyte hypertrophy. FASEB J 13:1985-1990 (Pubitemid 29517628)
48. Terpstra L, Prud'homme J, Arabian A, Takeda S, Karsenty G, Dedhar S, St-Arnaud R 2003 Reduced chondrocyte proliferation and chondrodysplasia in mice lacking the integrin-linked kinase in chondrocytes. J Cell Biol 162:139-148 (Pubitemid 36859541)
49. Stewart MC, Kadlcek RM, Robbins PD, MacLeod JN, Ballock RT 2004 Expression and activity of the CDK inhibitor p57Kip2 in chondrocytes undergoing hypertrophic differentiation. J Bone Miner Res 19:123-132 (Pubitemid 41295145)
50. Zhang P, Liégeois NJ, Wong C, Finegold M, Hou H, Thompson JC, Silverman A, Harper JW, DePinho RA, Elledge SJ 1997 Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387:151-158 (Pubitemid 27209424)
51. Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M, Johnson RS 2001 Hypoxia in cartilage: HIF-1α is essential for chondrocyte growth arrest and survival. Genes Dev 15:2865-2876 (Pubitemid 33042056)
52. MacLean HE, Guo J, Knight MC, Zhang P, Cobrinik D, Kronenberg HM 2004 The cyclin-dependent kinase inhibitor p57 (Kip2) mediates proliferative actions of PTHrP in chondrocytes. J Clin Invest 113:1334-1343 (Pubitemid 39089042)
53. Beier F, Leask TA, Haque S, Chow C, Taylor AC, Lee RJ, Pestell RG, Ballock RT, Lu Valle P 1999 Cell cycle genes in chondrocyte proliferation and differentiation. Matrix Biol 18:109-120 (Pubitemid 29229695)
54. Beier F 2005 Cell-cycle control and the cartilage growth plate. J Cell Physiol 202:1-8 (Pubitemid 39603357)
55. Holmen SL, Zylstra CR, Mukherjee A, Sigler RE, Faugere MC, Bouxsein ML, Deng L, Clemens TL, Williams BO 2005 Essential role of β-catenin in postnatal bone acquisition. J Biol Chem 280:21162-21168 (Pubitemid 40805677)
56. Chen M, Zhu M, Awad H, Li TF, Sheu TJ, Boyce BF, Chen D, O'Keefe RJ 2008 Inhibition of β-catenin signaling causes defects in postnatal cartilage development. J Cell Sci 121:1455-1465 (Pubitemid 351936310)
57. Tamamura Y, Otani T, Kanatani N, Koyama E, Kitagaki J, Komori T, Yamada Y, Costantini F, Wakisaka S, Pacifici M, Iwamoto M, Enomoto-Iwamoto M 2005 Developmental regulation of Wnt/β-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification. J Biol Chem 280:19185-19195 (Pubitemid 41379625)
58. Day TF, Guo X, Garrett-Beal L, Yang y 2005 Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8:739-750 (Pubitemid 40585296)
59. Dong YF, Soung do Y, Schwarz EM, O'Keefe RJ, Drissi H 2006 Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. J Cell Physiol 208:77-86 (Pubitemid 43848991)
60. Kapadia RM, Guntur AR, Reinhold MI, Naski MC 2005 Glycogen synthase kinase 3 controls endochondral bone development: contribution of fibroblast growth factor 18. Dev Biol 285:496-507 (Pubitemid 41394035)
61. Teixeira CC, Agoston H, Beier F 2008 Nitric oxide, C-type natriuretic peptide and cGMP as regulators of endochondral ossification. Dev Biol 319:171-178
62. Beier F, Loeser RF 2010 Biology and pathology of Rho GTPase, PI-3 kinase-Akt, and MAP kinase signaling pathways in chondrocytes. J Cell Biochem 110:573-580
63. Rokutanda S, Fujita T, Kanatani N, Yoshida CA, Komori H, Liu W, Mizuno A, Komori T 2009 Akt regulates skeletal development through GSK3, mTOR, and FoxOs. Dev Biol 328:78-93
64. James CG, Stanton LA, Agoston H, Ulici V, Underhill TM, Beier F 2010 Genome-wide analyses of gene expression during mouse endochondral ossification. PLoS One 5: e8693
65. Xu C, Kim NG, Gumbiner BM 2009 Regulation of protein stability by GSK3 mediated phosphorylation. Cell Cycle 8:4032-4039